Literature DB >> 26118903

Quantifying epitope presentation using mass spectrometry.

Nathan P Croft1, Anthony W Purcell2, David C Tscharke3.   

Abstract

Understanding the absolute quantities of MHC-bound epitopes (pMHC) presented on the surface of cells has long been a critical missing element in our knowledge of antigen presentation to T cells. Until recently, attaining such information has been restricted to the use of pMHC complex-specific monoclonal antibodies or T cell assays probing fractionated peptides eluted from cells. Although successful in a variety of cases, such approaches are limited in their scope and feasibility due to the nature of the reagents they are reliant upon. Here we report on the advancement of targeted mass spectrometry techniques to provide simultaneous and direct measurements of the relative and absolute levels of pMHC molecules and its potential for impact upon the field of antigen processing and presentation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Keywords:  Antigen processing and presentation; Epitope; MHC; Mass spectrometry

Mesh:

Substances:

Year:  2015        PMID: 26118903     DOI: 10.1016/j.molimm.2015.06.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  19 in total

Review 1.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

2.  Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Authors:  Bracha Shraibman; Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Gleb Slobodin; Itzhak Rosner; Carlos López-Larrea; Norbert Hilf; Sabrina Kuttruff; Colette Song; Cedrik Britten; John Castle; Sebastian Kreiter; Katrin Frenzel; Marcos Tatagiba; Ghazaleh Tabatabai; Pierre-Yves Dietrich; Valérie Dutoit; Wolfgang Wick; Michael Platten; Frank Winkler; Andreas von Deimling; Judith Kroep; Juan Sahuquillo; Francisco Martinez-Ricarte; Jordi Rodon; Ulrik Lassen; Christian Ottensmeier; Sjoerd H van der Burg; Per Thor Straten; Hans Skovgaard Poulsen; Berta Ponsati; Hideho Okada; Hans-Georg Rammensee; Ugur Sahin; Harpreet Singh; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2019-06       Impact factor: 5.911

3.  Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs.

Authors:  Ning Yang; James S Gibbs; Heather D Hickman; Glennys V Reynoso; Arun K Ghosh; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2016-03-25       Impact factor: 5.422

Review 4.  Potentiating prostate cancer immunotherapy with oncolytic viruses.

Authors:  Patrick Lee; Shashi Gujar
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

5.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

Review 6.  The melting pot of the MHC II peptidome.

Authors:  Lawrence J Stern; Laura Santambrogio
Journal:  Curr Opin Immunol       Date:  2016-03-25       Impact factor: 7.486

7.  Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames.

Authors:  Damien J Zanker; Sara Oveissi; David C Tscharke; Mubing Duan; Siyuan Wan; Xiaomu Zhang; Kun Xiao; Nicole A Mifsud; James Gibbs; Lenny Izzard; Daniel Dlugolenski; Pierre Faou; Karen L Laurie; Nathalie Vigneron; Ian G Barr; John Stambas; Benoît J Van den Eynde; Jack R Bennink; Jonathan W Yewdell; Weisan Chen
Journal:  J Immunol       Date:  2019-05-15       Impact factor: 5.422

8.  Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Authors:  Bracha Shraibman; Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Gleb Slobodin; Itzhak Rosner; Carlos López-Larrea; Norbert Hilf; Sabrina Kuttruff; Colette Song; Cedrik Britten; John Castle; Sebastian Kreiter; Katrin Frenzel; Marcos Tatagiba; Ghazaleh Tabatabai; Pierre-Yves Dietrich; Valérie Dutoit; Wolfgang Wick; Michael Platten; Frank Winkler; Andreas von Deimling; Judith Kroep; Juan Sahuquillo; Francisco Martinez-Ricarte; Jordi Rodon; Ulrik Lassen; Christian Ottensmeier; Sjoerd H van der Burg; Per Thor Straten; Hans Skovgaard Poulsen; Berta Ponsati; Hideho Okada; Hans-Georg Rammensee; Ugur Sahin; Harpreet Singh; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2018-08-02       Impact factor: 5.911

Review 9.  Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection.

Authors:  Komi Gbedande; Victor H Carpio; Robin Stephens
Journal:  Immunol Rev       Date:  2020-01       Impact factor: 12.988

10.  Direct Priming of CD8+ T Cells Persists in the Face of Cowpox Virus Inhibitors of Antigen Presentation.

Authors:  Leon C W Lin; Sarah N Croft; Nathan P Croft; Yik Chun Wong; Stewart A Smith; Swee-Seong Tang; Anthony W Purcell; David C Tscharke
Journal:  J Virol       Date:  2021-03-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.